Guangdong Hybribio Biotech Co.,Ltd. announced that at the Annual General Meeting held on 15 April 2022, approved cash dividend (tax included) of CNY 3.50000000 per ten shares.
Guangdong Hybribio Biotech Co.,Ltd.
Equities
300639
CNE100002N51
Medical Equipment, Supplies & Distribution
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
5.87 CNY | -3.29% | -8.71% | -37.15% |
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-37.15% | 517M | |
-0.75% | 12.72B | |
-11.57% | 7.5B | |
+2.55% | 5.48B | |
+0.98% | 4.61B | |
+5.18% | 4.47B | |
-50.82% | 3.28B | |
+11.23% | 2.71B | |
-18.08% | 2.02B | |
-10.84% | 1.74B |
- Stock Market
- Equities
- 300639 Stock
- News Guangdong Hybribio Biotech Co.,Ltd.
- Guangdong Hybribio Biotech Co.,Ltd. Approves Cash Dividend